Focus on Cancer: Precision Oncology in Head and Neck Cancer

Research News
Authored by
Michelle Venus
Julie Bauman, MD, MPH
Julie Bauman, MD, MPH, Dr. Cyrus Katzen Family Director of the GW Cancer Center

Discover how precision oncology is transforming the treatment of head and neck cancers. 

Julie Bauman, MD, MPH, Dr. Cyrus Katzen Family Director of the GW Cancer Center, explains how tumor profiling, molecular testing, and targeted therapies are helping clinicians personalize care, improve outcomes, and reduce unnecessary side effects.

Dr. Bauman shares insights on:

  • What precision oncology means for patients with head and neck cancer
  • How genomic and biomarker testing guide individualized treatment decisions
  • Advances in targeted therapies and immunotherapy
  • The future of personalized cancer care and ongoing research

 

 

 

Latest News

Elmer Huerta
Celebrating a Legacy of Service: Elmer Huerta, MD, MPH, Retires After Nearly 50 Years of Transforming Cancer Prevention
After nearly 50 years of service in medicine and public health, the GW Cancer Center bids a heartfelt farewell to Elmer E. Huerta, MD, MPH, as he concluded his career at the GW Cancer Center with his retirement at the end of June 2026.
a closeup photo of a young boy holding up his shirt sleeve after receiving a vaccination. There is a bandaidon his arm.
Fewer Childhood Vaccinations Today Could Mean More Preventable Cancers Tomorrow
Childhood vaccination rates are declining across the United States, and the consequences are already becoming visible. In 2025, the nation recorded more than 1,300 measles cases, the highest annual total since 1992.
Janice Ferebee
A Family Story, A Survivor’s Voice
For Janice Ferebee, cancer is more than a diagnosis. It is a family story that spans generations, shapes conversations, and fuels a lifelong commitment to helping others live healthier, more informed lives.
About
Research
News & Events
For Patients
For Health Professionals